Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
56.90
-0.79 (-1.37%)
At close: Dec 5, 2025, 4:00 PM EST
56.96
+0.06 (0.11%)
After-hours: Dec 5, 2025, 7:35 PM EST
Nektar Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 1,157 | 172 | 108 | 425 | 2,493 | 3,050 | |
| Market Cap Growth | 509.18% | 59.16% | -74.63% | -82.96% | -18.24% | -19.68% | |
| Enterprise Value | 1,054 | 129 | -20 | 179 | 1,866 | 2,117 | |
| Last Close Price | 56.90 | 13.95 | 8.47 | 33.90 | 202.65 | 255.00 | |
| PS Ratio | 13.89 | 1.74 | 1.20 | 4.61 | 24.47 | 19.94 | |
| PB Ratio | 13.14 | 2.82 | 0.82 | 1.16 | 3.67 | 2.83 | |
| P/TBV Ratio | 13.60 | 2.82 | 0.82 | 1.46 | 4.14 | 3.05 | |
| EV/Sales Ratio | 16.84 | 1.31 | - | 1.94 | 18.31 | 13.84 | |
| Debt / Equity Ratio | 1.96 | 3.20 | 1.76 | 0.78 | 0.50 | 0.33 | |
| Asset Turnover | 0.21 | 0.28 | 0.16 | 0.10 | 0.08 | 0.09 | |
| Inventory Turnover | - | - | 1.91 | 1.24 | 1.60 | 1.39 | |
| Quick Ratio | 4.09 | 4.18 | 5.97 | 7.53 | 8.90 | 9.55 | |
| Current Ratio | 4.24 | 4.26 | 6.45 | 8.01 | 9.34 | 9.83 | |
| Return on Equity (ROE) | -180.24% | -124.10% | -110.95% | -70.39% | -59.64% | -35.80% | |
| Return on Assets (ROA) | -27.98% | -23.14% | -15.25% | -16.43% | -21.00% | -13.51% | |
| Return on Capital (ROIC) | -33.61% | -26.34% | -16.66% | -17.96% | -22.80% | -14.33% | |
| Return on Capital Employed (ROCE) | -58.00% | -53.60% | -39.00% | -37.40% | -43.20% | -26.70% | |
| Earnings Yield | -10.43% | -69.35% | -256.12% | -86.68% | -21.01% | -14.57% | |
| FCF Yield | -16.45% | -103.28% | -179.50% | -72.91% | -17.15% | -10.51% | |
| Buyback Yield / Dilution | -14.07% | -8.24% | -1.53% | -2.10% | -2.64% | -2.05% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.